Potential role for peroxisome proliferator activated receptor (PPAR) in preventing colon cancer

Gut

Volumn 52, Issue 9, 2003, Pages 1317-1322

  Jackson, L ^c   Wahli, W ^d   Michalik, L ^d   Watson, S A ^c   Morris, T ^c   Anderton, K ^e   Bell, D R ^c   Smith, J A ^c   Hawkey, C J ^a,c   Bennett, A J ^b,e  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

^e QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOCORTIN 5; MESSENGER RNA; METHYLCLOFENAPATE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROPIDIUM IODIDE; THYMIDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL GROWTH; COLON CANCER; CONTROLLED STUDY; FEMALE; GENETIC REGULATION; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; INTESTINE POLYP; MALE; MITOGENESIS; MOUSE; NONHUMAN; RIBONUCLEASE PROTECTION ASSAY; TUMOR GROWTH; WESTERN BLOTTING;

ANIMALS; ANTICARCINOGENIC AGENTS; CLOFENAPATE; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTESTINAL POLYPS; LIGANDS; MALE; MICE; MICE, INBRED C57BL; RANDOM ALLOCATION; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0042887520     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.52.9.1317     Document Type: Article

References (32)

1. Boyle P, Langman MJS. ABC of colorectal cancer epidemiology. BMJ 2000;321:805-8.
2. World Cancer Research Fund/American Institute for Cancer Research. Food Nutrition and the Prevention of Cancer: a Global Perspective. Washington, BANTA Book Group USA, 1997.
3. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1992;61:759-67.
4. Kinzler KW, Vogelstein B. Lessons from hereditary colon cancer. Cell 1996;87:159-70.
5. Isseman I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proiferators. Nature 1990;347:645-50.
6. Meade E, McIntyre TM, Zimmerman G, et al. Peroxisome proliferators enhanced cyclooxygenase-2-expression in epithelial cells. J Biol Chem 1999;274:8328-34.
7. Staels B, Koenig W, Habib A, et al. Activation of human aortic smooth-muscle cells is inhibited by PPAR alpha but not by PPAR gamma activators. Nature 1998;293:790-3.
8. Lehmann JM, Lenhard JM, Olivier BB, et al. Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti- inflammatory drugs. J Biol Chem 1997;272:3406-10.
9. Yu K, Bayona W, Kaleb CB, et al. Differential activation of the peroxisome proliferator activated receptors by eicosanoids. J Biol Chem 1995;270:23975-83.
10. Forman BM, Tontonoz P, Chen J, et al. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 1995;83:803-12.
11. Tong-Chuan HE, Chan TA, Vogelstein B, et al. PPAR delta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 1999;99:335-45.
12. Min/+ mice. Nat Med 1998;4:1053-7.
13. Saez E, Tontonoz P, Nelson MC, et al. Activation of the nuclear receptor PPAR gamma enhance colon polyp formation. Nat Med 1998;4:1058-61.
14. Auboeuf D, Rieusset J, Fajas L, et al. Tissue distribution and quantification of the expression of mRNAs of PPARs and liver alpha receptor in humans. Diabetes 1997;46:1319-27.
15. Takahashi M, Minamoto T, Yamashita N, et al. Effect of docosahexaenoic acid on azoxymethane-induced colon carcinogenesis in rats. Cancer Lett 1994;83:177-84.
16. Iigo M, Nakagawa T, Ishikawa C, et al. Inhibitory effects of docosahexaenoic acid on colon carcinoma 26 metastasis to the lung. Br J Cancer 1997;75:650-5.
17. Beck SA, Smith KL, Tisdale MJ. Anticachectic and antitumor effect of eicosapentaenoic acid and its effect on protein turnover. Cancer Res 1991;51:6089-93.
18. Anti M, Marra G, Armelao F, et al. Effect of omega-3 fatty acids on rectal mucosal cell proliferation in subjects at risk for colon cancer. Gastroenterology 1992;103:883-91.
19. Tanaka T, Kohno H, Yoshitani S, et al. Ligands for peroxisome proliferator activated- receptors α and γ inhibit chemically induced colitis and formation of aberrant crypt foci in rats. Cancer Res 2001;61:2424-8.
20. Dreyer C, Krey G, Keller H, et al. Control of the peroxisomal-oxidation pathway by a novel family of nuclear hormone receptors. Cell 1992;68:879-87.
21. Tugwood JD, Issemann I, Anderson RG, et al. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J 1992;11:433-9.
22. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 987;162:156-9.
23. Harley CB. Hybridization of oligo (dT) to RNA on nitrocellulose membrane. Gene Anal Tech 1987;4:17-22.
24. Fajas L, Auboeuf D, Raspe E, et al. The organisation, promoter analysis and expression of the human PPAR gamma gene. J Biol Chem 1997;272:18779-89.
25. Kirkland SC. Dome formation by a human colonic adenocarcinoma cell line (HCA7). Cancer Res 1985;45:3790-5
26. Vermes I, Haanen C, Reuttelingsperger CPM. A novel assay for apoptosis: Flow cytometric detection of phosphatidyiserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Method 1995;180:39-52.
27. Huin C, Coirriveau L, Bianchi A, et al. Differential expression of peroxisome proliferator-activated receptors (PPARs) in the developing human fetal digestive tract. J Histochem Cytochem 2000;48:603-11.
28. Cable S, Keller JM, Colin S, et al. Peroxisomes in human colon carcinomas. A cytochemical and biochemical study. Virchows Archiv B Cell Pathol 1992;62:221-6.
29. Brockman JA, Gupta RA, Du Bois RN. Activation of PPAR gamma leads to inhibition of anchorage-in dependant growth of human colorectal cancer cells. Gastroenterology 1998;115:1049-55.
30. Juge-Aubry C, Pernin A, Favez T, et al. DNA Binding properties of peroxisome proliferator activated receptor subtypes on various natural peroxisome proliferator response elements. J Biol Chem 1997;272:25252-9.
31. Tucker MJ, Orton TC. Comparative Toxicology of Hypolipadaemic Fibrates. London: Taylor and Francis Ltd, 1995:23-58.
32. Gervois P, Torra IP, Fruchart JC, et al. Regulation of lipid and lipoprotein metabolism by PPAR activators. Clin Chem Lab Med 2000;38:3-11.